<DOC>
	<DOCNO>NCT00567216</DOCNO>
	<brief_summary>Gastric variceal bleed high rebleeding rate even endoscopic variceal injection cyanoacrylate ( GVO ) consider first choice endoscopic treatment . Beta-blocker ( BB ) effective low portal pressure . We hypothesize combination GVO BB decrease rebleeding rate .</brief_summary>
	<brief_title>Endoscopic Cyanoacrylate Obliteration vs. Nadolol Treatment Prevention Gastric Variceal Rebleeding</brief_title>
	<detailed_description>Gastric varies ( GV ) rarely rupture . However occur , outcome would worse rupture esophageal varies ( EV ) . Rupture GV characteristic high rebleeding rate , requirement large amount blood transfusion high mortality . Up date , treatment GV bleeding ( GVB ) still sub-optimal contrast treatment EV bleeding . The management GV focus treatment acute GVB . Various specific method use control GVB prevent rebleeding ; however far ideal . It GV usually large vessel form deep submucosa connect spontaneous gastrorenal shunt creates fast blood flow . Therefore , voluminous blood large diameter GV lead exsanguine bleeding rupture . A variety endoscopic method , include injection sclerosants , tissue adhesive ( cyanoacrylate ) , thrombin ligation rubber band , detachable nylon loop steel snare , apply control acute GV bleeding variable successful rate ( 50~100 % ) rebleeding rate ( 20~90 % ) . The successful rate endoscopic cyanoacrylate injection arrest active GVB consistent around 90~100 % rebleeding rate around 30~40 % . The recent International Consensus Meeting endorse endoscopic cyanoacrylate injection first line treatment acute GVB . The embolic complication , either septic &amp; aseptic , uncommon . Expertise also require reduce embolic complication instrumental injury . Therefore , efficacy specific treatment GVB sub-optimal , consecutive innovation new method require improve prognosis GVB . Non-selective beta-blocker effective reduce rebleeding esophageal varix . However , effect gastric variceal hemorrhage never proven . This important issue prompt current portal hypertension expert . We much experience treatment gastric variceal bleed publish fruitful result high ranking journal . Therefore , design randomize trial compare effect endoscopic cyanoacrylate injection obliteration versus non-selective beta-blocker secondary prevention acute gastric variceal bleeding .</detailed_description>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Nadolol</mesh_term>
	<criteria>clinical diagnosis liver cirrhosis and/or HCC , endoscopically proven gastric variceal bleed young 18 y/o old 80 y/o , terminal illness , major systemic disease malignancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2010</verification_date>
</DOC>